Using remote ischemic preconditioning to prevent kidney injury during coronary angiograms
Official title: Effectiveness of Remote Ischemic Preconditioning for Prevention of Contrast Induced Acute Kidney Injury in Patients Undergoing Coronary Angiograms.
Run by The University of Texas Medical Branch, Galveston · NCT05147831 · Data updated 2026-11-12
This study is testing if a simple treatment called remote ischemic preconditioning can help protect the kidneys from injury during coronary angiograms in patients who are at risk.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | The University of Texas Medical Branch, Galveston Academic / other |
| Locations | 1 site (Galveston, Texas) |
| Status | Recruiting |
| Started | November 30, 2021 |
| Main results expected | July 31, 2027 |
| Study ends | November 30, 2027 |
| Registry record updated | October 5, 2026 |
| Trial ID | NCT05147831 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include patients with renal clearance below 60 ml/min who are undergoing interventional or diagnostic procedures involving contrast media.
✕Probably not a fit
Patients on dialysis, those under 18 years old, or those with certain medical conditions that prevent RIPC will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effectiveness of remote ischemic preconditioning (RIPC) as a preventive measure against contrast-induced acute kidney injury (CI-AKI) in patients undergoing coronary angiograms. CI-AKI is a significant risk associated with the use of contrast media during imaging procedures, leading to serious health complications. The study aims to determine if RIPC can reduce the rise in creatinine levels and the incidence of renal replacement therapy in moderate to high-risk patients. By employing a non-invasive and low-cost approach, the research seeks to establish a safe method to mitigate the risks of CI-AKI.
Why it matters
Potential benefit: If successful, this intervention could significantly reduce the incidence of kidney injury in patients undergoing coronary angiograms.
How similar studies have gone: While the concept of remote ischemic preconditioning is promising, further randomized controlled trials are needed to confirm its effectiveness in preventing CI-AKI.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * (1) Patients undergoing an interventional or diagnostic radiological procedure in which they receive intravascular contrast, including patients undergoing coronary angiogram +/- percutaneous coronary intervention (PCI) for all clinical indications except those indicated for primary PCI due to STEMI * (2) patients presenting with a renal clearance in the range of less than 60 ml/min/1.73 m2 but not declared ESRD * (3) Patients who are not yet recruited for other pharmacological or medical device clinical trials. Exclusion Criteria: * (1) Age \<18 years * (2) Patient on hemodialysis or peritoneal dialysis * (3) Simultaneous participation in another interventional study * (4) Percutaneous coiling/embolization procedures of the kidney * (5) Impossibility to perform RIPC, caused by pathology in both arms (e.g. dystrophy, recent trauma, chronic wounds) * (6) No written informed consent * (7) Urgent angiography in STEMI * (8) Cardiogenic shock requiring catecholamine infusion * (9) Systolic blood pressure \<80 mmHg * (10) Intra-aortic balloon counter-pulsation * (11) Contrast medium injection within the previous 30 days * (12) Expected impossibility to obtain follow-up data at 6-week follow-up * (13) Patients with Raynaud's disease
Where it's running
-
University of Texas- Medical Branch (UTMB)
Galveston, Texas, United States Recruiting
Study contacts
- Study coordinator: Salman Salehin, MD
- Email: sasalehi@utmb.edu
- Phone: +12818189321
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Mechanical ventilation strategy to protect the lungs in obese adults during laparoscopic or robotic surgery
This trial tests whether a specific intraoperative PEEP approach that uses transpulmonary pressure to limit lung power can improve breathing after surgery for adults with BMI 35 or higher undergoing laparoscopic or robotic procedures.
-
Prenatal education to reduce environmental exposures during pregnancy
Aimed at pregnant people, this program tests whether a classroom-style education can help reduce exposure to harmful pollutants from seafood and nearby pollution sources.
-
Using CSNAT with home-based care to help caregivers of older adults
This study tests whether the Carer Support Needs Assessment Tool (CSNAT) given to family caregivers of older adults receiving home-based care helps reduce caregiver stress and supports their health and well-being.
-
Vibration or cool-spray to reduce pain from steroid injections in the hand and wrist
This trial tests whether vibration or vapocoolant spray makes corticosteroid injections in the hands, wrists, or elbows less painful for adults with arthritis, tendinopathy, or nerve compression.
-
Technology-assisted home strength training for adults 55–80 with type 2 diabetes and mild cognitive impairment
This 12-week program will test whether a telehealth-supported home strength-training routine helps adults 55–80 with type 2 diabetes and mild cognitive impairment stick with exercise and improve strength, thinking, and blood sugar.
-
External carotid artery stimulation for migraine
This test tries electrical stimulation of the external carotid artery to see if it helps adults with chronic or hard-to-treat migraines during a middle meningeal artery lidocaine infusion.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.